Doorley, James D. http://orcid.org/0000-0001-9080-4915
Greenberg, Jonathan http://orcid.org/0000-0002-4875-2207
Bakhshaie, Jafar http://orcid.org/0000-0002-5906-1292
Fishbein, Nathan S. http://orcid.org/0000-0003-0769-4896
Vranceanu, Ana-Maria http://orcid.org/0000-0003-3994-6488
Clinical trials referenced in this document:
Documents that mention this clinical trial
Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis
https://doi.org/10.1007/s11060-021-03852-1
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial
https://doi.org/10.1007/s11060-022-04104-6
Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis
https://doi.org/10.1007/s11060-021-03826-3
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-17-1-0121)
Article History
Received: 25 June 2021
Accepted: 11 August 2021
First Online: 19 August 2021
Declarations
:
: Each author certifies that he or she has no conflicts of interest to disclose.
: The authors certify that this study was approved by the Massachusetts General Hospital Institutional Review Board and was performed in accordance with the ethical standards set forth in the 1964 Declaration of Helsinki and its later amendments.
: The authors certify that all participants provided informed consent to participate in the study. The authors certify that, as part of the informed consent process, all study participants consent to having their de-identified data published within a scientific journal article.